Gülten Oskay-Oezcelik Selected Research

Drug Therapy (Chemotherapy)

1/2017	Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.
1/2015	NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis.
12/2009	Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gülten Oskay-Oezcelik Research Topics

Disease

3	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 12/2009
2	Carcinoma (Carcinomatosis) 05/2010 - 12/2009
1	Leukopenia 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Ascites 01/2017
1	Febrile Neutropenia 01/2015
1	Neutropenia 01/2015
1	Neoplasms (Cancer) 12/2009

Drug/Important Bio-Agent (IBA)

1	treosulfanIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	pegfilgrastim (Neulasta)FDA Link 01/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015
1	Adenosine Triphosphate (ATP)IBA 05/2010
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2010
1	RNA (Ribonucleic Acid)IBA 05/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2009
1	Carboplatin (JM8)FDA LinkGeneric 12/2009
1	enzastaurinIBA 12/2009

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2017 - 12/2009
2	Therapeutics 05/2010 - 12/2009